Professor Carsten Flohr

Qualifications

FRCP (London), FRCPCH (London), PhD , BM, BCh (Oxford), MPhil (Cambridge), MSc

GMC number: 4548249

Practising since: 1999

Specialties

Dermatology, Paediatrics

Consultation times

  • Wednesday PM
  • Overview
Enquire now

Or call us on

01483 555907

About

Prof Flohr is Director of the Centre for Dermatology and Immunology at the Guildford Nuffield Hospital.

He studied at Oxford and Cambridge Universities and is Professor of Dermatology and Consultant Dermatologist at St John’s Institute of Dermatology, Guy’s & St Thomas’ Hospital London, one of the world’s leading centres for patients with skin disease. 

Prof Flohr covers the full spectrum of adult dermatology conditions and is a Fellow of the Royal College of Physicians (FRCP). He is also an expert in paediatric dermatology and is one of a handful of UK dermatologists who hold a Fellowship of the Royal College of Paediatrics & Child Health (FRCPCH).

Special interests

All skin conditions, including:

  • Skin cancer (melanoma and non-melanoma skin cancer)
  • Mole screening
  • Dermoscopy
  • Skin surgery
  • Eczema (atopic eczema)
  • Allergy testing (skin prick testing and patch testing)
  • Psoriasis
  • Urticaria & angioedema
  • Contact allergy
  • Birth marks
  • Vascular anomalies and tumours
  • Acne
  • UV (light) therapy

Treatments and tests offered by Professor Carsten Flohr at Nuffield Health

  • Skin surgery
  • Cryotherapy
  • Skin cancer surgery
  • Allergy testing
  • Mole assessment
  • Dermoscope
  • Excision of skin lesion

Locations Professor Carsten Flohr works with

Related experience

Research

Professor Flohr holds the Chair in Dermatology and Population Health Science at St John’s Institute of Dermatology, King’s College London.

Carsten Flohr studied at Cambridge and Oxford Universities and then trained in both paediatrics and dermatology. 

He was the first UK National Institute for Health Research (NIHR) Clinician Scientist in Dermatology (2009-2014) and the only dermatologist awarded a Career Development Fellowship from the NIHR (2014-2019). 

He is Chief Investigator/Principal Investigator of several national and international studies, including the UK-Irish TREatment of severe eczema in children Trial (TREAT) and the UK-Irish Atopic Eczema Systemic Therapy Register (A-STAR), as well as the EU-funded BIOMAP and Trans-Foods consortia.

Prof Flohr is a Founding Director of the International Eczema Council and Past President of the British Society of Paediatric Dermatology, as well as an Honorary Member of the Société Française de Dermatologie.

He is Co-Lead of the European (EuroGuiDerm/European Dermatology Forum) management guidelines for atopic dermatitis, Founding Editor of the Evidence-Based Dermatology Section of the British Journal of Dermatology and the Clinical Trials Editor of the F1000 Atopic Dermatitis Section.

Memberships

  • British Association of Dermatologists
  • British Society for Dermatological Surgery
  • British Society for Paediatric Dermatology
  • British Society for Allergy and Clinical Immunology
  • European Academy for Allergy and Clinical Immunology

Other posts held

  • Professor and Consultant Dermatologist
  • St John’s Institute of Dermatology
  • Guy’s & St Thomas’s Hospital NHS Foundation Trust London

Insurers Professor Carsten Flohr works with

Professor Carsten Flohr works with the following private medical insurance providers:

  • Aviva Health
  • AXA Health
  • AXA - Global Healthcare
  • Benenden Health
  • Bupa
  • Cigna
  • CS Healthcare
  • Exeter Family Friendly
  • HealthFund
  • Simplyhealth
  • Universal Provident
  • Vitality Health (Pru Health)
  • WPA

Declaration

Professor Carsten Flohr does not hold a share or financial interest in this hospital, another Nuffield Health hospital or the company.

Professor Carsten Flohr does not have a share or financial interest in equipment used at this hospital or another Nuffield Health hospital.

Professor Carsten Flohr does not hold any paid advisory role(s) at this hospital or on behalf of Nuffield Health.